250 related articles for article (PubMed ID: 24260122)
21. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
[TBL] [Abstract][Full Text] [Related]
22. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
23. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
[TBL] [Abstract][Full Text] [Related]
24. Allergen-induced synthesis of interleukin-5, but not of IgE, is a key mechanism linked to symptomatic episodes of seasonal allergic rhinitis in sensitized individuals.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Washio Y; Yamada K; Hayashi M; Ohmoto Y
Scand J Immunol; 1998 Jun; 47(6):596-602. PubMed ID: 9652829
[TBL] [Abstract][Full Text] [Related]
25. Females have stronger neurogenic response than males after non-specific nasal challenge in patients with seasonal allergic rhinitis.
Tomljenovic D; Baudoin T; Megla ZB; Geber G; Scadding G; Kalogjera L
Med Hypotheses; 2018 Jul; 116():114-118. PubMed ID: 29857893
[TBL] [Abstract][Full Text] [Related]
26. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
[TBL] [Abstract][Full Text] [Related]
27. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
[TBL] [Abstract][Full Text] [Related]
28. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
[TBL] [Abstract][Full Text] [Related]
29. The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge.
Nicholson GC; Kariyawasam HH; Tan AJ; Hohlfeld JM; Quinn D; Walker C; Rodman D; Westwick J; Jurcevic S; Kon OM; Barnes PJ; Krug N; Hansel TT
J Allergy Clin Immunol; 2011 Oct; 128(4):800-807.e9. PubMed ID: 21719078
[TBL] [Abstract][Full Text] [Related]
30. Measurement of changes in mRNA for IL-5 in noninvasive scrapings of nasal epithelium taken from patients undergoing nasal allergen challenge.
Dreskin SC; Dale SN; Foster SM; Martin D; Buchmeier A; Nelson HS
J Immunol Methods; 2002 Oct; 268(2):189-95. PubMed ID: 12215387
[TBL] [Abstract][Full Text] [Related]
31. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
[TBL] [Abstract][Full Text] [Related]
32. Nasal immunotherapy in weed-induced allergic rhinitis.
Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Broccoli Sprout Extract on Seasonal Grass Pollen-Induced Allergic Rhinitis.
Yusin J; Wang V; Henning SM; Yang J; Tseng CH; Thames G; Arnold I; Heber D; Lee RP; Sanavio L; Pan Y; Qin T; Li Z
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920642
[TBL] [Abstract][Full Text] [Related]
34. Seasonal Local Allergic Rhinitis in Areas With High Concentrations of Grass Pollen.
Blanca-Lopez N; Campo P; Salas M; García Rodríguez C; Palomares F; Blanca M; Canto G; Feo Brito F; Rondon C
J Investig Allergol Clin Immunol; 2016; 26(2):83-91. PubMed ID: 27164623
[TBL] [Abstract][Full Text] [Related]
35. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
36. Nasal IL-13 production identifies patients with late-phase allergic responses.
Campion NJ; Villazala-Merino S; Thwaites RS; Stanek V; Killick H; Pertsinidou E; Zghaebi M; Toth J; Fröschl R; Perkmann T; Gangl K; Schneider S; Ristl R; Scott IC; Cohen ES; Molin M; Focke-Tejkl M; Regelsberger G; Hansel TT; Valenta R; Niederberger-Leppin V; Eckl-Dorna J
J Allergy Clin Immunol; 2023 Nov; 152(5):1167-1178.e12. PubMed ID: 37536510
[TBL] [Abstract][Full Text] [Related]
37. Nasal allergen-neutralizing IgG
Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
[TBL] [Abstract][Full Text] [Related]
38. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
[TBL] [Abstract][Full Text] [Related]
39. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
[TBL] [Abstract][Full Text] [Related]
40. Nasal and ocular responses after specific and nonspecific nasal challenges in seasonal allergic rhinitis.
Tomljenovic D; Baudoin T; Megla ZB; Vagic D; Hellings P; Kalogjera L
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):199-205. PubMed ID: 26804667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
